Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellul...
Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis
About this item
Full title
Author / Creator
Fan, Wenzhe , Zhu, Bowen , Yue, Shufan , Zheng, Xinlin , Zou, Xinhua , Li, Fuliang , Qiao, Liangliang , Wu, Yanqin , Xue, Miao , Wang, Hongyu , Tang, Yiyang and Li, Jiaping
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Aims
To investigate the efficacy and safety of lenvatinib and idarubicin‐loaded drug‐eluting beads transarterial chemoembolization (IDADEB‐TACE) in primary advanced hepatocellular carcinoma (HCC).
Methods
This retrospective study included patients with primary advanced HCC who received either lenvatinib monotherapy or lenvatinib plus IDADE...
Alternative Titles
Full title
Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_afba5db5ad3a407cbdfa86e252923c55
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_afba5db5ad3a407cbdfa86e252923c55
Other Identifiers
ISSN
2045-7634
E-ISSN
2045-7634
DOI
10.1002/cam4.4937
